|Articles|April 3, 2023

Syngene Utilizes New Innovation in the Manufacturing Value Chain

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Related Content

Drug manufacturing process. Conveyor with medical ampoules line at a modern pharmaceutical plant. Pharmacology production, medicine industry from laboratory 2 factory, pharmacy. Healthcare, pharma 3D | Image credit: © Corona Borealis - © Corona Borealis - stock.adobe.com

Samsung Biologics Bolsters US Manufacturing Network with GSK Facility Buy

ByFeliza Mirasol

December 22nd 2025

A man in protective clothing with test tubes in his hands against the background of a laboratory bioreactor.Experiments in the field of Microbiology. Pharmaceutical research.Synthesis of new chemicals | Image credit: © Grispb - © Grispb - stock.adobe.com

Rentschler–Coriolis Partnership Reflects Demand for Connected Biopharma Workflows

ByFeliza Mirasol

December 2nd 2025

GSK company office, British multinational pharmaceutical and biotechnology company. WARSAW, POLAND - APRIL 13, 2025 | Image Credit: © OleksKao - stock.adobe.com

GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment

ByPatrick Lavery

November 19th 2025

Data technology background. Big data visualization. Flow of data. Information code. Background in a matrix style. 4k rendering. | Image Credit: © Dmitry - stock.adobe.com

Weighing Digitalization Efficiency Against Upskilling and Quality Concerns

ByPatrick Lavery

November 17th 2025

Brain neurons in lysosomal storage diseases, 3D illustration | Image Credit: © Dr_Microbe - stock.adobe.com

Chiesi–Aliada Partnership Advances BBB-Crossing Technology for Lysosomal Storage Disorders

ByPatrick Lavery

November 13th 2025

Syngene Utilizes New Innovation in the Manufacturing Value Chain

Newsletter

Related Content

Samsung Biologics Bolsters US Manufacturing Network with GSK Facility Buy

Rentschler–Coriolis Partnership Reflects Demand for Connected Biopharma Workflows

GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment

Weighing Digitalization Efficiency Against Upskilling and Quality Concerns

Chiesi–Aliada Partnership Advances BBB-Crossing Technology for Lysosomal Storage Disorders

Trending on BioPharm International

Samsung Biologics Bolsters US Manufacturing Network with GSK Facility Buy

Novel Delivery Approaches of Biopharmaceuticals 2025

GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics

EMA Director Highlights Agency Achievements in 2025

FAQ: What Precision Analytics Have Done to Advance Next-Gen Biologics